Our Enterprise System Transition is in Progress. As expected with a change of this size, you may notice temporary delays in order processing & shipment. We’re committed to working through this period as quickly and smoothly as possible. Thank you for your patience and partnership.
  • Liberator Australia
  • P R C Saltillo Canada
  • Prentke Romich Deutschland
  • Liberator UK
  • P R C Saltillo Singapore
Select Language

Consider, Try, And Trial: What Is The Difference?

Published November 15, 2021

Consideration of alternatives: As part of an SGD evaluation, the SLP must discuss other device alternatives that could be used to treat the client’s condition. Consideration of alternatives, first for appropriateness and then for cost, is a required element of all SGD evaluation and reporting guidelines (Lewis Golinker, Esq., Public School Students: Who Can Pay for SGDs?, https://www.youtube.com/watch?v=O08OJopBH9s).

Funding sources have different guideline requirements for what constitutes an adequate “consideration of alternatives." Some funding sources require that you consider and rule out (for the client’s use), other device alternatives. Some require that you show that other device alternatives were tried. And yet, some funding sources require an extended trial of a certain length. The following is a discussion of how to know what the difference is between consider, try, and trial as those terms relate to consideration of device alternatives in an SGD evaluation.

The difference between Consider, Try, and Trial:

Funding source guidelines differ in what is required to satisfactorily rule out device alternatives for a client. Some state Medicaid plans require that all other lower cost alternatives must be “considered” and ruled out for the client’s use, AND that an extended “trial” of the recommended device must be completed prior to purchase. Conversely, Medicare only requires that the SGD evaluation report documents the other forms of treatment (other SGD’s) that were “considered” and ruled out for the client’s use. Medicare does not require documentation of an extended device trial of any length. Given that there are these differences among the various funding sources, it is important that SLPs reference SGD policy guidelines for their client’s funding source to assure that the SGD alternatives for their client are satisfactorily considered, tried, or trialed, based on the requirements in the policy guidelines.

PRC-Saltillo will accommodate a trial request, from the SLP or family, even if the funding source doesn’t require it. Check out aacfunding.com/borrow for options!


Beth Studdiford, M.S., CCC-SLP, and Beth Browning, M.A., CCC-SLP.

AAC Funding

Related Posts

Profile Image for related blog article titled A Modern Twist To Minspeak Symbols Products

A Modern Twist To Minspeak Symbols

Published August 17, 2026

A new modern version of Minspeak® multi-meaning symbols will be coming to Accent® (Empower® software), NovaChat®, and Via®/iOS devices with their respective software updates this fall.


Read More 
Profile Image for related blog article titled End Of Sale Notice: Accent 800 And 1000 And NuPoint Head Tracking Modules Products

End Of Sale Notice: Accent 800 And 1000 And NuPoint Head Tracking Modules

Published August 13, 2026

Learn about the retirement of Accent and NuPoint AAC products, important purchasing deadlines, support resources, and next-generation communication solutions.


Read More